$IPHA
AI 分析生成於 May 15, 2026
AI Score
Hold$IPHA
Innate Pharma S.A.
$IPHANASDAQTechnologyMid-Cap
Innate Pharma S.A. is a publicly traded company. Detailed information is being updated.
Market Cap
N/A
Revenue (TTM)
N/A
N/A
Net Income (TTM)
N/A
N/A
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend Yield
0.0%
52-Week Range
N/A
Beta
1.00
Dimension Scores
Fundamental
50Technical
50Sentiment
50Risk / Reward
50Momentum
50Financial Health
Profitability
55weak
Growth
53weak
Liquidity
58strong
Solvency
52moderate
Efficiency
48moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $IPHA
Free · No credit card required
免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。